Skip to Main Content

Author Details

Carl J Fichtenbaum
University of Cincinnati
1988
166
43
PMIDPaper TitleJournal TitlePublished Year
35975297Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).Clin Infect Dis2023
37486775Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.N Engl J Med2023
37503623Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.AIDS2023
37869406Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus.Open Forum Infect Dis2023
37439633Pericoronary Adipose Tissue Density, Inflammation, and Subclinical Coronary Artery Disease Among People With HIV in the REPRIEVE Cohort.Clin Infect Dis2023
37368931Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.J Acquir Immune Defic Syndr2023
36969259Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV.Front Immunol2023
37200479Research Initiative Supporting Excellence at the University of Cincinnati (RISE-UC): A Program to Develop and Support Research-Active Faculty Members.Acad Med2023
36966617Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV.EBioMedicine2023
36998633Coronary Artery Plaque Composition and Severity Relate to the Inflammasome in People With Treated Human Immunodeficiency Virus.Open Forum Infect Dis2023
36695364Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?AIDS2023
36805331Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.JCI Insight2023
36462699The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.Contemp Clin Trials2023
36825498Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE).Clin Infect Dis2023
36525544Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.AIDS2023
36101518Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.Clin Infect Dis2023
34181726Reply to Chu et al.Clin Infect Dis2022
35535576Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.J Infect Dis2022
35413022Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.J Acquir Immune Defic Syndr2022
36570965Pro-Inflammatory Alterations of Circulating Monocytes in Latent Tuberculosis Infection.Open Forum Infect Dis2022
35982307Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2.Nat Med2022
35876637Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk.AIDS2022
35147583Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).J Acquir Immune Defic Syndr2022
34934022Is it time to retire efavirenz as a first-line option worldwide?AIDS2022
35235653Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.Clin Infect Dis2022
35165682Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.Clin Infect Dis2022
34794178COVID-19 Vaccination Rates in a Global HIV Cohort.J Infect Dis2022
32115629Bearing the Burden of Non-AIDS Comorbidities: This Is What Women Aging With Human Immunodefiency Virus Look Like.Clin Infect Dis2021
34888397A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy.Open Forum Infect Dis2021
34888395Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.Open Forum Infect Dis2021
34551225Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.N Engl J Med2021
34621992Take Your Best Shot: Which SARS-CoV-2 Vaccine Should I Get?MDM Policy Pract2021
34185068Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.JAMA Netw Open2021
34134131Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.Clin Infect Dis2021
34081073Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.JAMA2021
33252496Monocyte activation in persons living with HIV and tuberculosis coinfection.AIDS2021
33068427Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.J Infect Dis2021
31135883Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).J Infect Dis2020
33391278<i>Mycobacterium bovis</i> Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis.Front Immunol2020
33174854Web-Based Data Collection for Older Adults Living With HIV in a Clinical Research Setting: Pilot Observational Study.J Med Internet Res2020
32352910Endovascular Therapy for Patients With Acute Ischemic Stroke During the COVID-19 Pandemic: A Proposed Algorithm.Stroke2020
32160827Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordination.HIV Res Clin Pract2020
30928823Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.Am Heart J2019
30219823Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.Clin Infect Dis2019
31232617Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection.Expert Opin Pharmacother2019
30895201No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial.Open Forum Infect Dis2019
30939531Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.J Acquir Immune Defic Syndr2019
31139758Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART.Pathog Immun2019
30928825Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).Am Heart J2019
29293895Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial.Clin Infect Dis2018
  • 1 - 50 of 166

Recommended Authors

Maria Mazzitelli
Padua University Hospital
Career Start Year 2016
Number of shared co-authors 1
Onyema Ogbuagu
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 3
Vincent Lo Re
IRCCS-ISMETT
Career Start Year 2001
Number of shared co-authors 3
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Tassos C Kyriakides
Yale School of Public Health
Career Start Year 1999
Number of shared co-authors 0
Matthias Cavassini
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 4
Carlo Torti
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 6
Charles B Hare
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 3
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 10
Roger Paredes
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 8
Todd Hulgan
Vanderbilt University Medical Center
Career Start Year 1992
Number of shared co-authors 7
Miguel Torralba
Hospital Universitario de Guadalajara
Career Start Year 1991
Number of shared co-authors 2
Kelly A Gebo
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 10
Janet Andersen
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 10
Andy I M Hoepelman
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 4
Gabriella Orlando
Azienda Ospedaliero-Universitaria, University of Modena and Reggio Emilia
Career Start Year 1988
Number of shared co-authors 2
Virginia L Kan
VA Medical Center
Career Start Year 1986
Number of shared co-authors 4
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 6
Elizabeth Cooney
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 3
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 5
Matthew Bidwell Goetz
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 5
Peter Bacchetti
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 8
Barbara Gripshover
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 7
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 9
Paul Volberding
Institute for Global Health Sciences, University of California san francisco
Career Start Year 1977
Number of shared co-authors 12
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 6
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 4
John Allen McCutchan
University of California San Diego
Career Start Year 1975
Number of shared co-authors 7
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 6
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 14

Collaborators

Heather J Ribaudo
Co-authored papers 32
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Co-authored papers 26
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Co-authored papers 26
Michael S Lyons
The Ohio State University College of Medicine
Co-authored papers 14
Christopher J Lindsell
Duke University
Co-authored papers 12
Alexander T Trott
University of Cincinnati College of Medicine
Co-authored papers 10
Andrew H Ruffner
University of Cincinnati College of Medicine
Co-authored papers 9
Tricia H Burdo
Co-authored papers 8
Kimberly W Hart
Vanderbilt University Medical Center
Co-authored papers 7
Joseph J Eron
Co-authored papers 7
Paul E Sax
Co-authored papers 7
Michael S Saag
University of Alabama at Birmingham
Co-authored papers 6
Pablo Tebas
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 6
Scott R Evans
Milken Institute School of Public Health, George Washington University
Co-authored papers 4
Rajesh T Gandhi
Co-authored papers 4
Jeffrey M Jacobson
Co-authored papers 4
Diane B Wayne
Northwestern University Feinberg School of Medicine
Co-authored papers 4
David A Wohl
The University of North Carolina School of Medicine
Co-authored papers 4
David B Clifford
Washington University School of Medicine
Co-authored papers 4
Michael M Lederman
Co-authored papers 3
Christopher R deFilippi
Co-authored papers 3
Dana L Raab
Co-authored papers 3
Matthew I Sperling
University of Cincinnati
Co-authored papers 3
Laura Smeaton
Harvard TH Chan School of Public Health
Co-authored papers 3
David W Haas
Vanderbilt University Medical Center
Co-authored papers 3
Vincent C Marconi
Co-authored papers 3
Daniel R Kuritzkes
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Peter T Frame
University of Michigan ann arbor
Co-authored papers 2
Jos?? R Arribas
La Paz University Hospital
Co-authored papers 2
Eileen King
Cincinnati Children's Hospital Medical Center
Co-authored papers 2
Release 1.2